To build capacity at the European, country and local levels by providing the evidence base and collecting best practises to prevent the harmful use of alcohol amongst older people, including the transition from work to retirement.


The project ICARE4EU aims to contribute to the innovation of care for European citizens with multiple chronic conditions by increasing and disseminating knowledge of potentially effective and efficient models of integrated care for people with multiple chronic conditions that are developed and implemented in (parts of) European countries. The vast majority of people with multimorbidity are older individuals. Integrated care addresses their integral needs for health and social care, and is provided by multidisciplinary teams of professionals and/or informal carers.
ICARE4EU will describe the state of the art in 30 European countries; evaluate the strengths and weaknesses of current integrated care programmes; identify best practices from different perspectives; generate knowledge about key characteristics and conditions for successful management and implementation of integrated care programmes; design a template for future monitoring of the developments in multimorbidity chronic illness care; and disseminate its findings throughout Europe.



The aim of the project is to collect empirical, reliable and representative data on the magnitude, characteristics and determinants of abuse of elders, and its health and well-being outcomes. The project will also contribute to the development of evidence-based policies, research and practice strategies aimed at early detecting and preventing abuse, but also at intervening to support/care of the abused elder individuals.


SIMPATHY aims to stimulate, promote and support innovation across the EU in the management of appropriate polypharmacy and adherence in the elderly, in order to contribute to efficient and sustainable healthcare systems. Through a programme of work and stakeholder engagement we will perform case studies in a range of different healthcare environments, including EIP-AHA reference sites, providing a framework and politico-economic basis for an EU wide benchmarking survey of strategies being employed for polypharmacy and non-adherence management. This includes innovative multidisciplinary models using the professional expertise of pharmacists and physicians to reduce inappropriate polypharmacy and innovation in healthcare workforce development to support patients with long term conditions. A set of contextualised change management approaches and tools will be developed to help politicians, regulators, health service providers, and other stakeholders to improve current practice by implementing organisational change and thus, improve the management of multi-morbid patients. The targeted dissemination of our validated findings and the creation of EU knowledge sharing network on polypharmacy and adherence management will support policy development, implementation of strategic organisational development and exchange of best practice to prepare the ground for necessary change in response to this major challenge. The anticipated outcomes will be a heightened awareness of this growing problem and an impetus for change. Information against which to benchmark regional and national progress, definitive guidance on the role of key stakeholders and how to initiate and manage this change process and will be available for the first time. The final ambition is to secure commitment of high-level political, healthcare providers, commissioners and professional associations to a task-force to address this evident threat to the sustainability of EU healthcare systems.
